Testosterone Therapy: Treatment of Metabolic Disturbances in Heart Failure
HF is a chronic multisystem disease process which is wrought with significant morbidity,
mortality and is burdensome on the health care system.
Optimal medical management is oftentimes inadequate in fully controlling symptoms.
As the end stage of HF results in a catabolic, pro-inflammatory condition,
more attention to the effects of metabolic therapies is needed.
The testosterone deficiency found in chronic HF patients may represent
a contributing element to symptom status.
Testosterone Supplementation has been shown to improve functional,
biochemical and several prognostic markers in patients with HF.
More research is necessary to fully understand the potential for Testosterone therapy in HF.
Testosterone Therapy: Treatment of Metabolic Disturbances in HF
Pros and Cons of HGH Therapy in Cardiovascular Disease Heart Failure
Statistics: 1 - 2% of total world population Prevalence 0.1% ca. 500,000
patients in US probability to survive 40 - 80% (1 year), 10 - 50 % (5 years).
Therapy in Cardiovascular Disease Heart Failure
- Decreased exercise tolerance
- Dyspnea - Orthopnea
- Fluid retention / edema
- End-stage: Cachexia